Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells

Innate Immunity

Volumn 18, Issue 2, 2012, Pages 204-216

  Güttsches, Anne Katrin ^a   Löseke, Stefan ^a   Zähringer, Ulrich ^b   Sonnenborn, Ulrich ^c   Enders, Corinne ^c   Gatermann, Sören ^a   Bufe, Albrecht ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Research Center Borstel   (Germany)

^c Ardeypharm GmbH   (Germany)

Author keywords

E. coli Nissle 1917; IL 10; LPS; microarray; O antigen chain; peripheral blood monocyte cells; probiotic

Indexed keywords

CYTOKINE; EOTAXIN 2; INTERLEUKIN 10; INTERLEUKIN 12P40; LIPOPOLYSACCHARIDE; PROBIOTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DOWN REGULATION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; UPREGULATION;

ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CHEMOKINE CCL24; DNA, COMPLEMENTARY; ENDOPEPTIDASE K; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MICROARRAY ANALYSIS; MONOCYTES; PROBIOTICS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ESCHERICHIA COLI NISSLE 1917;

EID: 84858428953     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425910396251     Document Type: Article

References (33)

1. Blum G, Marre R, Hacker J. Properties of Escherichia coli strains of serotype O6. Infection. 1995 ; 23: 234-236
2. Henker J, Laass M, Blokhin BM, et al. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur J Pediatr. 2007 ; 166: 311-318 (Pubitemid 46295098)
3. Zigra PI, Maipa VE, Alamanos YP. Probiotics and remission of ulcerative colitis: a systematic review. Netherlands J Med. 2007 ; 65: 411-418
4. Fujimori S, Tatsuguchi A, Gudis K, et al. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease. J Gastroenterol Hepatol. 2007 ; 22: 1199-1204 (Pubitemid 47222645)
5. LodinovaZadnikova R, Sonnenborn U. Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Biol Neonate. 1997 ; 71: 224-232 (Pubitemid 27153776)
6. Patzer SI, Baquero MR, Bravo D, Moreno F, Hantke K. The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology. 2003 ; 149: 2557-2570 (Pubitemid 37160730)
7. Grozdanov L, Raasch C, Schulze E, et al. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol. 2004 ; 186: 5432-5441 (Pubitemid 39038145)
8. Stentebjerg-Olesen B, Chakraborty T, Klemm P. Type 1 fimbriation and phase switching in a natural Escherichia coli fimB null strain, Nissle 1917. J Bacteriol. 1999 ; 181: 7470-7478
9. Blum-Oehler G, Oswald S, Eiteljorge K, et al. Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples. Res Microbiol. 2003 ; 154: 59-66 (Pubitemid 36165168)
10. Grozdanov L, Zähringer U, Blum-Oehler G, et al. A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J Bacteriol. 2002 ; 184: 5912-5925 (Pubitemid 35168240)
11. Porat R, Mosseri R, Kaplan E, Johns MA, Shibolet S. Distribution of polysaccharide side-chains of lipopolysaccharide determine resistance of Escherichia coli to the bactericidal activity of serum. J Infect Dis. 1992 ; 165: 953-956
12. Philpott DJ, Girardin SE. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol. 2004 ; 41: 1099-1108 (Pubitemid 39345391)
13. Huang H, Park CK, Ryu JY, et al. Expression profiling of lipopolysaccharide target genes in RAW264.7 cells by oligonucleotide microarray analyses. Arch Pharmacol Res. 2006 ; 29: 890-897 (Pubitemid 44808456)
14. Casals C, Barrachina M, Serra M, Lloberas J, Celada A. Lipopolysaccharide up-regulates MHC class II expression on dendritic cells through an AP-1 enhancer without affecting the levels of C11TA. J Immunol. 2007 ; 178: 6307-6315 (Pubitemid 46717414)
15. Boirivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol. 2007 ; 23: 679-692 (Pubitemid 47508800)
16. Berger H, Hacker J, Juarez A, Hughes C, Goebel W. Cloning of the chromosomal determinants encoding hemolysin production and mannose-resistant hemagglutination in Escherichia coli. J Bacteriol. 1982 ; 152: 1241-1247 (Pubitemid 13190430)
17. Grozdanov L, Zähringer U, Blum-Oehler G, et al. A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J Bacteriol. 2002 ; 184: 5912-5925 (Pubitemid 35168240)
18. Murphy D. Gene expression studies using microarrays: principles, problems, and prospects. Adv Physiol Educ. 2002 ; 26: 256-270
19. Tsuchiya M, Piras V, Choi S, et al. Emergent genome-wide control in wildtype and genetically mutated lipopolysaccarides-stimulated macrophages. PLoS One. 2009 ; 4: 1-13
20. Löseke S, Grage-Griebenow E, Wagner A, Gehlhar K, Bufe A. Differential expression of IFN-α subtypes in human PBMCs; evaluation of novel real-time PCR assays. J Immunol Methods. 2003 ; 276: 207-222 (Pubitemid 36513851)
21. Kauth M, Grage-Griebenow E, Rohde G, et al. Synergistically up regulated IL-10 production in co-cultures of alveolar macrophages and T cells after infection with respiratory syncytial virus in vitro. Int Arch Allergy Immunol. 2007 ; 142: 116-126 (Pubitemid 46095923)
22. Huber M, Kalis C, Keck S, et al. R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur J Immunol. 2006 ; 36: 701-711
23. Gangloff SC, Zahringer U, Blondin C, Guenounou M, Silver J, Goyert SM. Influence of CD14 on ligand interactions between lipopolysaccharide and its receptor complex. J Immunol. 2005 ; 175: 3940-3945 (Pubitemid 41292055)
24. Brekke OL, Christiansen D, Fure H, et al. Combined inhibition of complement and CD14 abolish E. coli-induced cytokine, chemokine and growth factor synthesis in human whole blood. Mol Immunol. 2008 ; 45: 3804-3813
25. Gutierrez-Ramos JC, Lloyd C, Gonzalo JA. Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions. Immunol Today. 1999 ; 20: 500-504 (Pubitemid 29507093)
26. Mir A, Minguez M, Tatay J, et al. Elevated serum eotaxin levels in patients with inflammatory bowel disease. Am J Gastroenterol. 2002 ; 97: 1452-1457 (Pubitemid 34664791)
27. Zhou L, Nazarian AA, Smale ST. Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway. Mol Cell Biol. 2004 ; 24: 2385-2396 (Pubitemid 38325995)
28. Lammers KM, Brigidi P, Vitali B, et al. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol. 2003 ; 38: 165-172 (Pubitemid 37297842)
29. Berenson CS, Murphy TF, Wrona CT, Sethi S. Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines. Infect Immun. 2005 ; 73: 2728-2735 (Pubitemid 40570338)
30. Wang JE, Jorgensen PF, Almlof M, et al. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun. 2000 ; 68: 3965-3970 (Pubitemid 30434548)
31. McGuirk P, Mills KHG. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol. 2000 ; 30: 415-422 (Pubitemid 30098833)
32. Sing A, Reithmeier-Rost D, Granfors K, Hill J, Roggenkamp A, Heesemann J. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc Natl Acad Sci USA. 2005 ; 102: 16049-16054 (Pubitemid 41552865)
33. Kamada N, Maeda K, Inoue N, et al. Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. Infect Immun. 2008 ; 76: 214-220